AUDREY FILLERS are manufactured by Ostin Bio, Co., Ltd using hyaluronic acid derived from non-animal origins with high purity; hence it is biocompatible when injected into the body. AUDREY FILLERS are composed of highly purified and internationally recognized derivatives of hyaluronic acid that constantly maintain elasticity in the skin.
AUDREY FILLERS are developed with MSFT or Multiple Swelling Formulation Technology, a core method patented by Ostin Bio. It is a method where the hyaluronic acid in the dermal filler uses minimal cross-linking agents. It uses a blend of gels with different swelling ratios to increase hydration and safely maintain volume once injected into the skin. This innovative procedure gives AUDREY FILLERS an excellent volume effect, outstanding tissue adhesion, and high cohesiveness. It also minimizes free radical formation by significantly reducing proteins that may cause hypersensitivity reactions. Upon clinical trials, AUDREY FILLERS shows low unit levels of endotoxin, thus holding an outstanding safety profile.
AUDREY FILLERS come in different variants according to their consistency. The hard variation of the AUDREY Filler is manufactured with a higher viscosity and more volume than the soft type, thus resulting in a more robust shaping capacity after injection. It somehow prevents deformation and can be effective for a longer duration.
China 
